Constitutive expression of major histocompatibility complex class II (MHC II) antigens normally occurs in B-lymphocytes and antigen presenting cells of the monocyte/macrophage lineage. However, many malignant tumours and transformed cells express these proteins aberrantly. We demonstrate here that the MHC II DRa promoter is constitutively active both In the SV40 large T antigen transformed cell line, COS, and in CV1 cells from which they are derived. As an approach to understanding the molecular mechanisms underlying aberrant DRa expression we have examined the cisand trans-acting requirements for DRa transcription in these cell types. Electrophoretic mobility shift assays showed that the region immediately 3' to the X-box was bound by a member of the ATF/CREB family of transcription factors. Using deletions and point mutations in the DRa promoter we demonstrate that, in contrast to B-cells, the octamer motif and conserved X-and Y-boxes make only a minor contribution to promoter function while single point mutations in the ATF/CREB motif reduced transcription up to 20-fold. In addition, we show that the DRa promoter is activated by SV40 large T-antlgen and that activation requires an intact ATF/CREB motif. Similar data were obtained using B16 melanoma cells . These results suggest that the ATF/CREB motif may be a target for transcription deregulation in several transformed cell types.
INTRODUCTION
The mammalian Major Histocompatibility Complex (MHC) class II genes encode a polymorphic series of heterodimeric glycoproteins of the immunoglobulin family which play a crucial role in antigen presentation (1) . Constitutive expression is normally restricted to B-lymphocytes and antigen presenting cells of the monocyte/macrophage lineage while expression in many other cell types is induced by exposure to cytokines such as interferon y, TNFa and interleukin 4. Regulation of MHC class II expression occurs largely at the transcriptional level, and the class II MHC promoters share a number of conserved sequence elements, the X, Y and W boxes, that, at least in some cases, are known to bind transcription factors and are required for transcription in B-cells (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Unlike other members of the family, the DRa promoter contains an octamer motif which is also necessary for efficient expression in B-lymphoccytes (20) .
In addition to the constitutive expression observed in B-cells, MHC II antigens are also expressed on the surface of many malignant tumours and transformed cell lines (21) , but although the requirements for expression in B-cells have been studied in some detail those for inappropriate expression in transformed cells have not yet been examined. Several mechanisms for the transcriptional deregulation of the MHC class II genes might be envisaged. For example, cell-type specific factors, such as OCT-2 or the X-box-binding proteins may be inappropriately expressed or activated in transformed cell types. Alternatively, the potential of transcription factors present in class II negative cell types to activate class II expression may be greatly enhanced by transformation induced changes in post-translational modification. It is also conceivable that transformed cells express novel transcription regulators that fortuitously interact with and activate class II genes. With increasing evidence that transcription deregulation plays a major role in the oncogenic transformation of cells (22, 23 ) the MHC II genes offer an opportunity to identify the cis-and transacting factors that may be involved in this process.
In this study we examine the requirements for the inappropriate expression of the DRa promoter. We show that the MHC II DRa promoter is constitutively active at high levels in the SV40 large T antigen-transformed cell line COS. In contrast to B-cells, the X, Y and octamer elements play only a minor role in regulation, and expression is directed by a previously poorly characterised ATF/CREB binding site located immediately adjacent to the Xbox. Significantly SV40 T-antigen can activate transcription from the MHC II DRa promoter by up to 13-fold in CV1 cells with activation requiring an intact ATF/CREB motif. Similar results were also obtained using the B16 melanoma cell line. Cell lines, transfections and /3-galactosidase assays  CV1, SV40 transformed COS-1 cells and B16 F10 melanoma  cells obtained from the American Type Culture Collection, were  maintained in Dulbecco's modified Eagle's medium (DMEM)  supplemented with 10% newborn calf serum. Cells (5X1O   5   ) , were transfected 24 hours after plating by calcium phosphate coprecipitation of lOmg DNA in BBS (COS-1 and B16) or HBS (CV-1). Following a 4 hr exposure to the co-precipitate, cells were washed once with DMEM, exposed to 15% glycerol in DMEM for 30 seconds (CV-1 and B16), washed again and both cell lines grown for a further 48 hours in complete growth medium prior to assay. Promoter activity in was measured using j3-galactosidase assays as described (24, 25) .
MATERIALS AND METHODS

Plasmid constructions, Bal 31 deletions and mutagenesis
The DRa promoter extending from position -184 to +43 was cloned, after addition of 5' Sal I and 3' HinD m sites by PCR, upstream of the lac Z reporter gene in plasmid pSVOdlacZ (kindly provided by E.Blair) to generate DRlacZ. 5' deletions were prepared by restriction with Sal 1, digestion with Bal31 and, after addition of an Xba I linker, deletion end-points were confirmed by sequencing. Appropriate deletions were then subcloned into the pSVOdlacZ. Point mutations were created by oligonucleotide site-directed mutagenesis using the 'Mutagene' kit (BioRad). The SV40 large T antigen expression plasmid CMV-T, and CMVIL2 from which it was derived and the control plasmid pCHl 10 were gifts from Drs J.Jenkins, and C.Kedinger respectively.
Preparation of nuclear extracts and electrophoretic mobility shift assays (EMSA) Nuclear extracts were prepared as described (26) from nuclei isolated from cells lysed in 5 volumes cold lysis buffer (10 mM Tris pH 7.0, lOmM NaCl, 2mM MgCy by addition of 50/il/ml 10% NP40. Dialysis of the nuclear extract was omitted for CV-1 extracts which were particularly labile.
A typical 20^1 EMSA reaction included: l/il nuclear extract; 50ng poly(dI.dC:dI.dC); 20cpm probe (c. O.lng) in GR buffer (15% glycerol, 150mM KC1, 1.5mM MgCl 2 , 50mM HEPES pH 7.9). In competition experiments 10 or lOOng of double stranded competitor oligonucleotide was added to the reaction 5 minutes prior to addition of the probe. All EMSAs were performed at room temperature apart from CV-1 which were incubated on ice. Reactions were electrophoresed through 8% low ionic strength acrylamide gels, fixed in 10% acetic acid, dried and exposed to XAR autoradiography film (Kodak) at -70°C.
RESULTS
Interaction of a factor with an ATF/CREB consensus sequence in the DRa promoter
Previous work has identified a number of cis-acting elements, the X-box, the Y-box and octamer motif, and their cognate factors required for efficient constitutive expression of the MHC class II DRa promoter in B-cells. However, it was not known whether these same elements were also required for the aberrant constitutive expression observed in many transformed cell types. transformed cell lines demonstrated that the DRa promoter was extremely active in the SV40 transformed monkey cell line COS-1. As an approach to understanding the molecular mechanisms underlying the aberrant expression of the DRa promoter in these cells we initially examined the nuclear proteins interacting with the conserved sequence elements. To this end we synthesised wild-type (WT) and mutant oligonucleotides corresponding to the X-box, Y-box and octamer motifs and used these in electrophoretic mobility shift assays (EMSA) with COS cell nuclear extracts. As expected the octamer element was recognised by the ubiquitous octamer-binding protein OCT-1 and the Y-box bound by the CCAAT transcription factor NFY (CRF) (not shown). However, the pattern of interactions observed using a probe encompassing the X-box was more complex. The DRa promoter is shown in Fig. la and sequences of the probes and competitors in Fig. lb . Using the WT X-box probe, DRXA, two major bands were observed (A and B in Fig. lc) . Both bands were efficiently competed using an homologous competitor, whilst DRxA, containing a double point mutation in the X-box, failed to compete. Interestingly, an oligonucleotide containing a WT X-box but with a single base change in the 3' flanking sequences (DRXal) competed efficiently for complex A, but less well for complex B. Oligonucleotides containing either the mutations in the X-box and its flanking sequence (DRxa) or the DQ X-box (DQX) failed to compete. These results suggest firstly that the factors recognising the X-box homologies of the MHC class II DRa and DQ/3 promoters were different and secondly that sequences outside the DRa X-box were important for the formation of complex B. Examination of the sequences 3' to the DRa X-box reveals a strong homology, ATGACGCATC, to the consensus sequence for the ATF/CREB family of transcription factors with a much weaker homology to the API motif (not shown). It was likely therefore that ATF/CREBwould bind this element. Although an ATF site from the adenovirus EIIL promoter competed neither for complex A nor for complex B (Fig. lc) it was possible that ATF binding was being masked by an X-box complex with the same mobility, a possibility supported by the results obtained using the DRXal and DRxA competitors in Fig. lc . To examine this possibility the DRXal and DRxA oligonucleotides were used as probes and binding activities competed using WT or mutant oligonucleotides (Fig. Id) . Using the DRXal probe, complex B was competed well by both the the WT oligonucleotide, DRXA, and ATF/CREB site mutant, DRXal, but not by the X-box mutant DRxA or the double mutant DRxa. In contrast, the complex bound by the DRxA probe, containing the mutant Xbox but WT ATF/CREB site, was only competed efficiently by those oligonucleotides containing WT ATF/CREB sites-DRXA and DRxA. Thus the X-box is recognised by two factors, A and Bl, while the ATF/CREB site binds factor B2. To confirm that the B2 complex indeed represents an ATF/CREB binding activity we next used either the DRxA probe or a probe containing the fibronectin ATF/CREB motif (FN ATF), together with competitors containing ATF/CREB sites from the somatostatin, EEL and fos promoters and an API (PEA1) site from the polyoma virus enhancer. These data (Fig. le and f) show conclusively that the ATF/CREB motifs from different promoters cross compete with that from DRa while no competition is observed using the API site.
The ATF/CREB recognition sequence is essential for DRa promoter function in COS-1 cells Our results showed that the DRa promoter bound an ATF/CREBlike factor, in addition to two X-box binding factors (A and Bl), as well as NF-Y, and OCT-1. To determine the relative contribution of these factors to DRa promoter activity in COS cells we compared the levels of /3-galactosidase activity produced after transfection using an expression vector containing the DRa sequences extending from position -184 to +43 placed upstream of the lacZ reporter gene (Fig. 2b) to that obtained after transfection of a series of 5' deletion mutants (Fig. 2a) that lacked one or more of these motifs. Removal of sequences upstream of the X-box (5'A-139) or the X-box itself (5'A-103) reduced promoter activity by around 30% (Fig. 3C) , indicating that in this cell type, in contrast to results obtained in B-cells (20) , the X-box may play a relatively minor role in DRa expression. However, removal of an additional lObp (5'A-93) reduced transcription to just 10% of wild type. Further deletion, removing the Y-box (5'A-67), abolished residual promoter activity and as such the effect of removing the octamer element (5'A-38) could not be measured using this deletion series. To assess the relative contribution of each of these elements within the context of the intact promoter we introduced double point mutations in the most highly conserved region of the X-box, Y-box and octamer elements and a single base change in the ATF/CREB motif (Fig. 2d) . Transfection of these mutated promoters into COS-1 cells again demonstrated the absolute importance of the ATF/CREB site; mutation of the octamer (pMo) and Y-box (pMy) had no significant effect on promoter function, transcription from the X-box mutant (pMx) was reduced by less than 2-fold, while a single point mutation at position -90 (pMa) decreased promoter activity by 20-fold (Fig. 2e) , although expression from the pMa promoter was still significantly above that of a promoter-less construct. Thus, both deletion and point mutational analysis indicate that the major cis-acting element contributing to DRa promoter function is the ATF/CREB site located immediately 3' to the X-box.
The ATF/CREB motif is required for induction of the DRa promoter by SV40 T-antigen
The efficient constitutive transcription of the DRa promoter in the SV40 transformed COS-1 cells, up to 50-fold greater than in the non-transformed parent CV1 cell line (not shown), prompted us to ask whether expresssion of DRa could be induced by the presence of SV40 T-antigen. CVl cells were therefore transfected with the DRa promoter derivatives and the effects of the point mutations determined. The results obtained show clearly that while mutations in the octamer (pMo), Y-box (pMy) and X-box (pMx) each decrease promoter activity by only 2-3 fold, the single base change at position -90 (pMa) reduces DRa transcription by 95% (Fig. 3a) . Co-transfection of the DRa-lacZ reporter gene with a vector expressing SV40 T-antigen under the control of the CMV immediate-early promoter induced DRa transcription typically by 5-fold, with up to 13-fold being obtained in some experiments (Fig. 3b) . No induction was observed by co-transfection of a CMV vector that did not express T-antigen. Since the DRa promoter does not contain a T-antigen DNAbinding site, transcription activation was likely to be mediated via a cellular transcription factor. In an attempt to define the target within the DRa promoter that was responsive to T-antigen we also transfected CVl cells with the series of promoter point mutations in the presence or absence of the T-antigen expression vector. Expression of SV40 T-antigen efficiently induced transcription from the X-box, Y-box and octamer mutants. However, in contrast no induction was detected using the pMa ATF/CREB point mutant, despite there being a measurable level of basal promoter activity compared to a promoter-less lac Z reporter gene. These results correlate well with the binding studies, since the oligonucleotide corresponding to pMa (DRXal) competes poorly for the ATF/CREB-like binding activity in COS or CVl extracts. We conclude therefore that the induction of the DRa promoter by SV40 T-antigen is most likely requires the factors) interacting with the ATF/CREB motif. II negative. To determine whether our observations could be extended we transfected the MHC class II positive melanoma cell line, B16 F10 (27) , with the wild-type and mutant DRalacZ fusions in the presence or absence of the T-antigen expressing plasmid CMVT. The results, shown in Fig. 4a and b, emphatically underline those obtained in COS and CVl cells. Mutation of the octamer, Y-box and X-box gave only a maximal 3-fold effect while the single point mutation in the ATF/CREB motif (pMa) drastically reduced constitutive promoter activity, at least 40-fold. Similarly the pMa mutant was not induced by T-antigen in contrast to the efficient induction obtained using the octamer, Y-box and X-box mutants. Thus, the requirements for aberrant DRa expression in CVl, COS and B16 melanoma cells are dramatically different from those required for normal, constitutive expression in B-cells and may reflect a general mechanism of transcription deregulation.
The ATF/CREB motif is also required for constitutive
DISCUSSION
The data presented in this paper show conclusively that the DRa promoter activity in CVl, COS and B16 melanoma cells is almost entirely dependent on sequences immediately 3' to the X-box and that this site is required for T-antigen-mediated activation of transcription. Both constitutive and induced expression correlate well with the binding to this sequence of a factor which appears likely to be a member of the ATF/CREB family of transcription factors, rather than an API-like protein such as the fos: jun heterodimer. The division of these structurally related proteins into two separate families was originally based on their different, but related, binding specificities, with the CRE, bound by ATF/CREB, conferring responsiveness to cAMP, calcium and adenovirus E1A products (28) (29) (30) , while the TRE was recognised by the API family and was activated by TPA, neuronal specific and differentiation-inducing stimuli. (31, 32) . However, this distinction has become less rigid with the demonstration of inter-as well as intra-family heterodimerisation (33, 34) , in some cases resulting in factors with altered DNAbinding specificity (35) . Thus, although the factor interacting with the ATF/CREB motif in the DRa promoter does not appear to be API we cannot rule out the participation of either fos or jun in the complex detected. The recent isolation of cDNAs encoding members of the bZIP class of proteins able to bind this sequence, either as homo or heterodimers, supports this possibility (36, 37) . Thus, hXBPl can bind the DRa promoter either as a homodimer or as a heterodimer with fos but not with jun (38, 39) , while mXBPl binds as a homodimer or as a heterodimer with jun (40) . In addition, API may also interact with the DRa ATF/CREB motif in MHC II non-expressing cells but surprisingly fos : jun heterodimers are not detected in expressing B-cells, even though fos and jun mRNA are readily detectable (41) . Since multiple members of the ATF/CREB and API families may be present in any one cell type it is likely that the ATF/CREB element in the DRa promoter can be recognised by multiple different complexes, mediating responses to a variety of signal transduction pathways. It is possible therefore that the proteins from COS and CVl cells we detect interacting with the DRa element are either an XBP1: fos/jun heterodimer, another related complex, perhaps involving heterodimerisation between the ATF/CREB and API families or perhaps multiple complexes with identical binding specificities. Indeed, given the nature of the DRa ATF/CREB element, any member of the ATF/CREB family has the potential to bind this element as a homodimer or heterodimer with other members of the family or with members of the jun/fos/fra family and may be involved in transcription regulation in vivo. It is as yet almost impossible to determine which combination of proteins is involved.
While it is evident that the ATF/CREB motif in the DRa promoter may interact with multiple different transcription factors it is not yet clear whether it is involved in constitutive DRa expression in B-lymphocytes. In one study disruption of the ATF/CREB motif had a 2-fold effect on constitutive DRa expression in RAJI cells (37) , while expression of antisense fos RNA reduced DRa promoter activity 4-fold in vivo and anti-fos antibody inhibited transcription in vitro (38) , providing indirect evidence for the involvement of the ATF/CREB motif. In direct contrast, another study reported no effect of mutating the ATF/CREB site (20) . In CV1 and COS cells, however, there is clearly a dramatic shift in the use of the DRa promoter elements with the ATF/CREB motif being essential for efficient and constitutive DRa promoter activity; in B-cells mutation of either the Y-box, X-box or octamer reduce DR expression at least 10-fold (20) whereas in CV1, COS and B16 melanoma cells the same elements play a relatively minor role, despite NF-Y, OCT-1 and X-box binding activities being readily detectable in these cells. It is tempting therefore to speculate that the inappropriate expression of DRa in many transformed cell types may reflect a deregulation of the factors interacting with the ATF/CREB motif.
Support for the idea that this element may be a target for deregulation of MHC class II expression in transformed cells comes from the observation that SV40 large T-antigen, a potent transforming agent (42) , can activate DRa transcription and that this activation requires the ATF/CREB motif. Indeed, the importance of the ATF/CREB motif in T-antigen mediated activation of transcription is underlined by the observation that the adenovirus EUaE and EDI promoters also possess ATF/CREB sites (43) and are activated by T-antigen (44, 45) . In addition to ATF/CREB it is likely that other transcription factors will also be responsive to T-antigen; in the SV40 late promoter, for example, evidence suggests that TEF-1, binding to the SPH/OCT motifs, may also be a target for T antigen-mediated transcription activation (46, 47) .
The mechanism by which T antigen activates transcription is not known. However, it does not appear to require DNA-binding since non-DNA-binding mutants still activate RSV LTR, SV40 late (48, 49) and DRa (P.Cox, unpublished observations) expression and a number of T-antigen responsive promoters lack T-binding sites. Similarly, mutants defective for the other known T antigen functions-nuclear localisation, p53 binding, ATPase activity, and retinoblastoma susceptibility protein binding-also transactivate the SV40 late and RSV LTR promoters (49) . Several possible models present themselves. These include a direct interaction between T-antigen and the ATF/ CREB factor, Tantigen induced post-translational modification of ATF/CREB, or involvement of other factors which may interact in a T-antigen dependent fashion directly with the ATF/CREB site or with the ATF/CREB factor itself. Although, we have found no obvious difference in binding to the DRa ATF/CREB motif activty when comparing CV1 and COS cell extracts (P.C. unpublished observations), this does not rule out the involvement of T-antigen induced post-translational modification, differences in selection of dimerisation partners by the ATF/CREB factor, nor, for that matter, involvement of other factors that are not readily detectable using in vitro assays. A further possibility which we find particularly attractive is that T antigen increases the effectiveness of some component of the general transcription machinery, resulting in stimulation of transcription from promoters containing a wide variety of transcription factor binding sites. Only those factors that are active in a particular promoter would therefore be potential targets; in the case of the DRa promoter this would be ATF/CREB since the X-box, Y-box and octamer motif make only a minor contribution to promoter function. This does not necessarily mean that T-antigen mediated transcription activation would be completely promiscuous since it is clear that some components of the basal transcription machinery exhibit promoter specificity (50) . Whatever mechanism operates, it is clear that if a similar deregulatory mechanism also occurs in cells in the absence of T antigen it might go some way towards explaining why DRa is aberrantly expressed in so many transformed cell types.
